Stockscreener 앱 받기
189.49
0.40%
-0.77
전일 마감가:
$190.26
열려 있는:
$189.4
하루 거래량:
1.13M
Relative Volume:
1.06
시가총액:
$21.08B
수익:
$10.52B
순이익/손실:
$999.00M
주가수익비율:
22.66
EPS:
8.3628
순현금흐름:
$1.22B
1주 성능:
+8.63%
1개월 성능:
+6.06%
6개월 성능:
+13.45%
1년 성능:
+24.94%
1일 변동 폭
$188.75
$190.96
1주일 범위
$173.51
$190.99
52주 변동 폭
$150.14
$197.55
퀘스트 다이아그노스틱스 Stock (DGX) Company Profile
명칭
Quest Diagnostics Inc
전화
(973) 520-2700
주소
500 PLAZA DRIVE, SECAUCUS
DGX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
DGX
Quest Diagnostics Inc
|
189.49 | 21.16B | 10.52B | 999.00M | 1.22B | 8.3628 |
|
TMO
Thermo Fisher Scientific Inc
|
618.72 | 234.69B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
235.99 | 169.45B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
715.37 | 56.86B | 4.17B | 1.03B | 940.22M | 12.61 |
|
IQV
Iqvia Holdings Inc
|
237.68 | 41.09B | 15.90B | 1.28B | 2.21B | 7.2842 |
|
A
Agilent Technologies Inc
|
139.64 | 41.06B | 6.95B | 1.30B | 1.15B | 4.5696 |
퀘스트 다이아그노스틱스 Stock (DGX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-08-25 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2025-04-02 | 개시 | Redburn Atlantic | Buy |
| 2025-03-04 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2025-01-06 | 업그레이드 | Leerink Partners | Market Perform → Outperform |
| 2024-12-17 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2024-12-10 | 재개 | Jefferies | Buy |
| 2024-10-23 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2024-08-28 | 재개 | Evercore ISI | In-line |
| 2024-07-10 | 업그레이드 | Citigroup | Neutral → Buy |
| 2024-02-26 | 개시 | Leerink Partners | Market Perform |
| 2024-02-07 | 업그레이드 | Jefferies | Hold → Buy |
| 2024-01-03 | 개시 | Barclays | Equal Weight |
| 2023-12-12 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2023-06-29 | 개시 | Piper Sandler | Neutral |
| 2023-05-02 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2023-04-03 | 업그레이드 | Citigroup | Sell → Neutral |
| 2023-01-23 | 개시 | Evercore ISI | In-line |
| 2022-11-17 | 다운그레이드 | Citigroup | Neutral → Sell |
| 2022-08-22 | 재개 | Morgan Stanley | Equal-Weight |
| 2022-04-04 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2022-02-23 | 다운그레이드 | UBS | Buy → Neutral |
| 2022-02-02 | 다운그레이드 | Jefferies | Buy → Hold |
| 2022-01-28 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2021-05-04 | 업그레이드 | UBS | Neutral → Buy |
| 2021-03-12 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2020-10-21 | 업그레이드 | Argus | Hold → Buy |
| 2020-07-29 | 업그레이드 | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2020-07-14 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2020-06-09 | 업그레이드 | Wells Fargo | Underweight → Equal Weight |
| 2020-06-02 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2020-04-28 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2020-04-27 | 업그레이드 | Citigroup | Neutral → Buy |
| 2020-04-27 | 업그레이드 | Wolfe Research | Underperform → Peer Perform |
| 2020-03-27 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2020-01-08 | 개시 | Wells Fargo | Underweight |
| 2020-01-07 | 다운그레이드 | Barclays | Overweight → Equal Weight |
| 2019-12-19 | 업그레이드 | BofA/Merrill | Underperform → Neutral |
| 2019-07-15 | 다운그레이드 | Goldman | Neutral → Sell |
| 2019-04-02 | 업그레이드 | Jefferies | Hold → Buy |
| 2019-03-18 | 재개 | Credit Suisse | Neutral |
| 2019-01-31 | 다운그레이드 | Argus | Buy → Hold |
| 2019-01-17 | 개시 | UBS | Neutral |
| 2019-01-03 | 다운그레이드 | BofA/Merrill | Neutral → Underperform |
| 2018-12-03 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
| 2018-11-30 | 다운그레이드 | Goldman | Buy → Neutral |
모두보기
퀘스트 다이아그노스틱스 주식(DGX)의 최신 뉴스
How Do Investors Really Feel About Quest Diagnostics Inc? - Benzinga
TKG Advisors LLC Raises Stake in Quest Diagnostics Incorporated $DGX - MarketBeat
Nordea Investment Management AB Trims Holdings in Quest Diagnostics Incorporated $DGX - MarketBeat
Aug PreEarnings: Is Quest Diagnostics Incorporated stock a value trapWatch List & AI Optimized Trade Strategies - baoquankhu1.vn
Quest Diagnostics Inc. (NYSE:DGX): A Prime Pick for Steady, Growing Dividends - Chartmill
Manning & Napier Advisors LLC Sells 11,341 Shares of Quest Diagnostics Incorporated $DGX - MarketBeat
Market Rankings: What are Quest Diagnostics Incorporateds earnings expectationsJuly 2025 Market Mood & Daily Technical Stock Forecast Reports - baoquankhu1.vn
Baird Adjusts Quest Diagnostics Price Target to $203 From $198, Maintains Neutral Rating - marketscreener.com
Quest Diagnostics Incorporated $DGX Shares Purchased by Nisa Investment Advisors LLC - MarketBeat
Best Testosterone Replacement Therapy (TRT) 2026: Taurus Meds Consumer Analysis Examines Online TRT Access and At-Home Testosterone Treatment Options - GlobeNewswire Inc.
SG Americas Securities LLC Sells 19,597 Shares of Quest Diagnostics Incorporated $DGX - MarketBeat
Is Quest Diagnostics (DGX) Stock Outpacing Its Medical Peers This Year? - Eastern Progress
Quest Diagnostics About To Put More Money In Your Pocket (DGX) - Nasdaq
How cyclical is Quest Diagnostics Incorporated (QDI) stock compared to rivalsGDP Growth & Free Safe Capital Growth Stock Tips - Улправда
Visby Engages Quest and Labcorp to Broaden Consumer Access to First At-Home, FDA-Authorized PCR Test for STIs - BioSpace
Quest Diagnostics to Release Fourth Quarter and Full Year 2025 Financial Results on February 10, 2026 - Finviz
Can Quest Diagnostics Incorporated stock sustain institutional interestJuly 2025 PostEarnings & Verified Swing Trading Watchlists - Улправда
New 30-minute at-home test helps women detect STIs privately - Stock Titan
Caldwell Trust Co Grows Holdings in Quest Diagnostics Incorporated $DGX - MarketBeat
Diagnostic testing leader will share its 2025 results on Feb. 10 - Stock Titan
Quest Diagnostics Incorporated (NYSE:DGX) Given Consensus Recommendation of "Hold" by Brokerages - MarketBeat
Is It Time To Reassess Quest Diagnostics (DGX) After Recent Share Price Strength? - Yahoo Finance
Quest Diagnostics (DGX) is a Top-Ranked Growth Stock: Should You Buy? - Nasdaq
Data Featuring Haystack MRD from Quest Diagnostics to be Presented at the 2026 ASCO Gastrointestinal Cancers Symposium - Finviz
Data Featuring Haystack MRD® from Quest Diagnostics to be Presented at the 2026 ASCO Gastrointestinal Cancers Symposium - MarketScreener
Data Featuring Haystack MRD® from Quest Diagnostics to be Presented at the 2026 ASCO Gastrointestinal Cancers Symposium – Company AnnouncementFT.com - Financial Times
Assessing Quest Diagnostics (DGX) Valuation After Recent Share Price Momentum And Perceived Undervaluation - Yahoo Finance
Corewell Health, Quest Diagnostics form joint venture - Modern Healthcare
Quest Diagnostics, Corewell Health Complete Laboratory JV in Michigan - MarketScreener
Palmetto Grain Brokerage - Palmetto Grain Brokerage
Corewell Health and Quest Diagnostics Complete Laboratory Joint Venture Transaction in Michigan - Finviz
What You Need To Know Ahead of Quest Diagnostics' Earnings Release - Barchart.com
Quest Diagnostics Incorporated $DGX Shares Sold by SteelPeak Wealth LLC - MarketBeat
Quest Diagnostics Find A Testfav Events Billing & Coding- - shababeek.org
RSI Alert: Quest Diagnostics Now Oversold - Nasdaq
Quest Diagnostics Incorporated $DGX Shares Purchased by Braun Stacey Associates Inc. - MarketBeat
Ethic Inc. Increases Stock Holdings in Quest Diagnostics Incorporated $DGX - MarketBeat
Q3 Earnings Highlights: Quest (NYSE:DGX) Vs The Rest Of The Testing & Diagnostics Services Stocks - Finviz
Boston Trust Walden Corp Sells 53,026 Shares of Quest Diagnostics Incorporated $DGX - MarketBeat
Quest Diagnostics (DGX) Upgraded to Buy: Here's Why - Yahoo Finance
Copeland Capital Management LLC Sells 7,889 Shares of Quest Diagnostics Incorporated $DGX - MarketBeat
Harbor Capital Advisors Inc. Has $596,000 Stake in Quest Diagnostics Incorporated $DGX - MarketBeat
Pacer Advisors Inc. Grows Stock Holdings in Quest Diagnostics Incorporated $DGX - MarketBeat
Assenagon Asset Management S.A. Lowers Stake in Quest Diagnostics Incorporated $DGX - MarketBeat
Is Quest Diagnostics Stock a Right Pick for Your Portfolio Now? - sharewise.com
Quest Diagnostics Incorporated $DGX Shares Sold by Coho Partners Ltd. - MarketBeat
Voya Investment Management LLC Reduces Stock Holdings in Quest Diagnostics Incorporated $DGX - MarketBeat
Thrivent Financial for Lutherans Purchases 11,351 Shares of Quest Diagnostics Incorporated $DGX - MarketBeat
Corient Private Wealth LLC Has $4.49 Million Stake in Quest Diagnostics Incorporated $DGX - MarketBeat
What is the fair value of Quest Diagnostics Incorporated stock now2025 Bull vs Bear & Expert Curated Trade Setups - Улправда
Quest Diagnostics to Speak at the 44th Annual J.P. Morgan Healthcare Conference - PR Newswire
퀘스트 다이아그노스틱스 (DGX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.51%
0.74%
자본화:
|
볼륨(24시간):